Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Caterina Polli is active.

Publication


Featured researches published by Caterina Polli.


International Journal of Radiation Oncology Biology Physics | 2007

CONE BEAM CT IMAGE GUIDANCE FOR INTRACRANIAL STEREOTACTIC TREATMENTS: COMPARISON WITH A FRAME GUIDED SET-UP

Laura Masi; F. Casamassima; Caterina Polli; C. Menichelli; I. Bonucci; Carlo Cavedon

PURPOSE An analysis is performed of the setup errors measured by a kV cone beam computed tomography (CBCT) for intracranial stereotactic radiotherapy (SRT) patients immobilized by a thermoplastic mask and a bite-block and positioned using stereotactic coordinates. We evaluated the overall positioning precision and accuracy of the immobilizing and localizing systems. The potential of image-guided radiotherapy to replace stereotactic methods is discussed. METHODS AND MATERIALS Fifty-seven patients received brain SRT. After a frame-guided setup, before each fraction (131 fractions), a CBCT was acquired and the detected displacements corrected online. Translational and rotational errors were analyzed calculating overall mean and standard deviation. A separate analysis was performed for bite-block (in conjunction with mask) and for simple thermoplastic mask. Interobserver variability for CBCT three-dimensional registration was assessed. The residual error after correction and intrafractional motion were calculated. RESULTS The mean module of the three-dimensional displacement vector was 3.0 +/- 1.4 mm. Setup errors for bite block and mask were smaller (2.9 +/- 1.3 mm) than those for thermoplastic mask alone (3.2 +/- 1.5 mm), but statistical significance was not reached (p = 0.15). Interobserver variability was negligible. The maximum margin calculated for residual errors and intra fraction motion was small but not negligible (1.57 mm). CONCLUSIONS Considering the detected setup errors, daily image guidance is essential for the efficacy of SRT treatments when mask immobilization is used, and even when a bite-block is used in conjunction. The frame setup is still used as a starting point for the opportunity of rotational corrections. Residual margins after on-line corrections must be evaluated.


Radiotherapy and Oncology | 2011

Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer

Nicola Pratesi; Monica Mangoni; Irene Mancini; Fabiola Paiar; Lisa Simi; Lorenzo Livi; Sara Cassani; Michela Buglione; Salvatore Grisanti; Camillo Almici; Caterina Polli; Calogero Saieva; Stefano Maria Magrini; Giampaolo Biti; Mario Pazzagli; Claudio Orlando

PURPOSE Individual variability in radiosensitivity is large in cancer patients. Single nucleotide polymorphisms (SNPs) in genes involved in DNA repair and in protection against reactive oxygen species (ROS) could be responsible for such cases of radiosensitivity. We investigated the association between the occurrence of acute reactions in 101 patients with squamous cell carcinoma of the head and neck (SCCHN) after radiotherapy (RT) and five genetic polymorphisms: XRCC1 c.1196A>G, XRCC3 c.722C>T, RAD51 (c.-3429G>C, c.-3392G>T), and GSTP1 c.313A>G. MATERIALS AND METHODS Genetic polymorphisms were detected by high resolution melting analysis (HRMA). The development of acute reactions (oral mucositis, skin erythema and dysphagia) associated with genetic polymorphisms was modeled using Cox proportional hazards, accounting for biologically effective dose (BED). RESULTS Development of grade ≥2 mucositis was increased in all patients (chemo-radiotherapy and radiotherapy alone) with XRCC1-399Gln allele (HR=1.72). The likelihood of developing grade ≥2 dysphagia was higher in carriers of RAD51 c.-3429 CC/GC genotypes (HR=4.00). The presence of at least one SNP or the co-presence of both SNPs in XRCC1 p.Gln399Arg /RAD51 c.-3429 G>C status were associated to higher likelihood of occurrence of acute toxicities (HR=2.03). CONCLUSIONS Our findings showed an association between genetic polymorphisms, XRCC1 c.1196A>G and RAD51 c.-3429 G>C, and the development of radiation-induced toxicities in SCCHN patients.


European Journal of Cancer | 2012

Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival

Michela Buglione; Salvatore Grisanti; Camillo Almici; Monica Mangoni; Caterina Polli; Francesca Consoli; Rosanna Verardi; Loredana Costa; Fabiola Paiar; Nadia Pasinetti; Andrea Bolzoni; Mirella Marini; Edda Simoncini; Piero Nicolai; G. Biti; Stefano Maria Magrini

BACKGROUND AND PURPOSE The mechanism of dissemination of locally advanced head and neck cancer (LAHNC) is far to be resolved. Circulating tumour cells (CTC) have been identified as a prognostic factor in metastatic breast and prostate cancer. This prospective multi-centric analysis studied the possible role of CTC identification in LAHNC. MATERIALS AND METHODS CTC were searched in 73 patients with LAHNC (oropharynx, n=39; nasopharynx, n=10; larynx, n=10; paranasal sinuses, n=6, of whom 3 with sinonasal undifferentiated carcinoma, SNUC; hypopharynx, n=5; oral cavity, n=3). All of them (apart from SNUC) had squamous cell cancers. The relationship between CTC positivity and other clinical prognostic factors has been investigated. Response to treatment and survival has been related with changes in CTC number during the treatment. RESULTS CTC were frequently identified in oro- and hypopharyngeal cancer and in SNUC. They were more frequent in stage IV than in stages I-III disease (18% versus 6%, p=NS (not significant)). Partial or complete response (CR) was related with the absence or disappearance of CTC during treatment (p=0.017). A decrease in the CTC number or their absence throughout the treatment seems also related with non-progressive disease, after both complete or incomplete remission and with the proportion of patients alive and NED (no evidence of disease) (p=0.009). CONCLUSIONS These preliminary data suggest a possible role of CTC determination in head and neck cancer. Additional and longer follow up data need to be collected to confirm these findings.


Acta Oncologica | 2008

On-line image guidance for frameless stereotactic radiotherapy of lung malignancies by cone beam CT: comparison between target localization and alignment on bony anatomy.

Laura Masi; F. Casamassima; C. Menichelli; Katia Pasciuti; Raffaela Doro; Caterina Polli; Elena D'imporzano; I. Bonucci

Introduction. Free-breathing stereotactic radiotherapy for lung malignancies requires reliable prediction of respiratory motion and accurate target localization. A protocol was adopted for reproducibility and reduction of respiratory motion and for target localization by CBCT image guidance. Tumor respiratory displacements and tumor positioning errors relative to bony anatomy alignment are analyzed. Materials and method. Image guided SRT was performed for 99 lung malignancies. Two groups of patients were considered: group A did not perform any breathing control; group B controlled visually their respiratory cycle and volumes on an Active Breathing Coordinator (ABC) monitor during the acquisition of simulation CT and CBCT, and treatment delivery. GTV on end inhale and exhale CT data sets were fused in an ITV and the extent of tumor motion evaluated between these 2 phases. A pre-treatment CBCT was acquired and aligned to the reference CT using bony anatomy; for tumor positioning the ITV contour on the reference CT was matched to the visible tumor on CBCT. Interobserver variability of tumor positioning was evaluated. ITV and CBCT tumor dimensions were compared. Results. 3D tumor breathing displacement (mean±SD) was significantly higher for group A (14.7±9.9 mm) than for group B (4.7±3.1 mm). The detected differences between tumor and bony structure alignment below 3 mm were 68% for group B and 45% for group A, reaching statistical significance. Interobserver variability was 1.7±1.1 mm (mean±SD). Dimensions of tumor image on CBCT were consistent with ITV dimensions for group B (max difference 14%). Conclusions. The adopted protocol seems effective in reducing respiratory internal movements and margin. Tumor positioning errors relative to bony anatomy are also reduced. However bony anatomy as a surrogate of the target may still lead to some relevant positioning errors. Target visualization on CBCT is essential for an accurate localization in lung SRT.


International Journal of Radiation Oncology Biology Physics | 2008

RELEVANCE OF BIOLOGICALLY EQUIVALENT DOSE VALUES IN OUTCOME EVALUATION OF STEREOTACTIC RADIOTHERAPY FOR LUNG NODULES

F. Casamassima; Laura Masi; I. Bonucci; Caterina Polli; C. Menichelli; Massimo Gulisano; Stefania Pacini; Stefano Aterini; Carlo Cavedon

PURPOSE Different biologically equivalent dose (BED) values associated with stereotactic radiotherapy (SRT) of patients with primary and metastatic pulmonary nodules were studied. The BED values were calculated for tumoral tissue and low alpha/beta ratio, assuming that better local response could be obtained by using stereotactic high-BED treatment. METHODS AND MATERIALS Fifty-eight patients with T1-T3 N0 non-small-cell lung cancer and 46 patients with metastatic lung nodules were treated with SRT. The BED was calculated for alpha/beta ratios of 3 and 10. Overall survival (OS) was assessed according to Kaplan-Meier and appraised as a function of three BED levels: low (30-50 Gy), medium (50-70 Gy), and high (70-98 Gy; alpha/beta = 10). RESULTS The OS rates for all 104 patients at 12, 24, and 36 months were 73%, 48.3%, and 35.8%, respectively. Local response greater than 50% for low, medium, and high BED values was observed in 54%, 47%, and 73%, respectively. In the high-BED treated group, OS rates at 12, 24, and 36 months (80.9%, 70%, and 53.6%, respectively) were significantly improved compared with low- (69%, 46.1%, and 30.7%, respectively) and medium-BED (67%, 28%, and 21%, respectively) treated patients. Results are also discussed in terms of BED calculated on alpha/beta 3 Gy characteristic of the microcapillary bed. No acute toxicity higher than Grade 1 was observed. CONCLUSIONS Radioablation of pulmonary neoplastic nodules may be achieved with SRT delivered by using a high-dose fraction with high BED value.


International Journal of Radiation Oncology Biology Physics | 2005

Radical radiotherapy for early glottic cancer: Results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease.

Paolo Frata; E. Cellai; Stefano Maria Magrini; Bartolomea Bonetti; E. Vitali; Sandro Tonoli; Michela Buglione; Fabiola Paiar; Raffaella Barca; Simona Fondelli; Caterina Polli; Lorenzo Livi; G. Biti


American Journal of Surgery | 2006

Late treatment–related complications in 214 patients with extremity soft-tissue sarcoma treated by surgery and postoperative radiation therapy

Lorenzo Livi; Riccardo Santoni; Fabiola Paiar; Paolo Bastiani; Giovanni Beltrami; Patrizio Caldora; Rodolfo Capanna; Pietro De Biase; Beatrice Detti; Simona Fondelli; Elisa Meldolesi; Maurizio Pertici; Caterina Polli; Gabriele Simontacchi; G. Biti


International Journal of Radiation Oncology Biology Physics | 2008

IGRT Stereotactic Hypofractionated Radiotherapy for Treatment of Focal Liver Malignancies

F. Casamassima; Laura Masi; C. Menichelli; E. D'Imporzano; Caterina Polli; I. Bonucci


Radiotherapy and Oncology | 2012

PD-0445 CIRCULATING TUMOR CELLS IN LOCALLY ADVANCED HEAD AND NECK CANCER: A POSSIBLE TOOL TO PREDICT RESPONSE TO TREATMENT?

Michela Buglione; G. Salvatore; Camillo Almici; Monica Mangoni; Caterina Polli; F. Consoli; Fabiola Paiar; Nadia Pasinetti; R. Verardi; Stefano Maria Magrini


Radiotherapy and Oncology | 2012

OC-30: Circulating Tumor Cells in Locally Advanced Head and Neck Cancer: A Possible Role to Predict Response to the Treatment

Michela Buglione; Salvatore Grisanti; Camillo Almici; Monica Mangoni; Caterina Polli; F. Consoli; R. Verardi; Fabiola Paiar; Nadia Pasinetti; Stefano Maria Magrini

Collaboration


Dive into the Caterina Polli's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

I. Bonucci

University of Florence

View shared research outputs
Top Co-Authors

Avatar

Laura Masi

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

G. Biti

University of Florence

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge